Found "Public health policy": 1,044 results
Sort by
Last updated

Off-label medicines: Rational or Irrational?

The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems. It is therefore important to have a rational an

Is it Worthwhile to Introduce Pneumococcal Conjugate Vaccine into the Routine Immunization Services?

In Bhutan, respiratory infections are some of the major causes of morbidity and mortality in children. Pneumonia, an infection of the lungs, is among the top 10 common causes of children’s death in the country. Not only does it impose costs on society that may not be immediately visible (e.g. produ

Your Friendly, Neighborhood GEAR Guide!

In 2015, a HITAP International Unit (HIU) survey identified the major challenges (both contextual and technical) to the conduct of rigorous economic evaluations for policymakers’ use in healthcare decision making. • From this study, HITAP created an online platform called the Guide to health Econ

National Health Examination Survey in Thailand Looking to the Past to Build a Better Future

The evaluation of public health in Thailand is conducted via the National Health Examination Survey (NHES). This programme has been implemented since 1991 and serves as an important source of health data due to comprehensive and accurate medical examinations conducted by medical personnel – which ar

Providing hearing aids alone is not enough After-provision services must also improve

People with hearing loss who are registered under the Universal Health Coverage scheme areeligible to receive hearing aids from hospitals free-of-charge. However, the costs associated with this policy after having received the hearing aids must still be borne by users such as hearing aid maintenance

Using Health Technology Assessment to address inefficient and unequal use of Nilotinib across Indonesia

It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo
10 / Page